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Short introduction 
Measurement of ambulatory blood pressure is recommended by the NICE 
guidelines to confirm the diagnosis of hypertension in the UK. In this report we 
describe the use of ambulatory devices and discuss the benefits and 
disadvantages of its use in clinical practice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Key points: 
1. Ambulatory blood pressure measurment (ABPM) offers certain advantages 
as a method of monitoring BP: reduced white-coat effect and an ability to 
assess BP variability, BP dipping at night, and presence of a morning BP 
surge 
2. ABPM has better correlation with  cardiovascular outcomes than clinic BP 
monitoring 
3. ABPM is the most accurate and cost-effective non-invasive (i.e. not intra-
arterial) method of diagnosing hypertension 
4. Recent research and guidelines recommend the routine use of ABPM for 
the diagnosis of hypertension 
5. It is important to follow correct procedure and to use an independently  
validated monitor 
 
Main Introduction 
Why measure blood pressure? 
Hypertension is a major cause of morbidity and mortality worldwide (Lim et al, 2012) 
and high blood pressure (BP) is a key risk factor for the development of 
cardiovascular disease (Prospective Studies Collaboration, 2002) by increasing the 
risk of myocardial infarction, stroke, congestive heart failure, and atherosclerosis. 
Accuracy in measuring blood pressure is fundamental to the correct diagnosis and 
good management of hypertension. 
 
Blood pressure is not static but undergoes natural variations from one heartbeat to 
another and varies in a circadian fashion throughout the day. This is dependent upon 
a number of factors including stress, nutritional factors, drugs, disease, exercise, and 
position. Therefore, any single reading represents only a snapshot of a much wider 
range of blood pressure values that a person has experienced during a given period. 
Repeated measurement therefore allows better estimation of the underlying blood 
pressure. 
 
What is ABPM? 
Ambulatory blood pressure measurement (ABPM) is a non-invasive method of 
obtaining blood pressure readings at regular intervals over twenty-four hours, whilst 
the patient is in their own environment, undertaking their usual activities. It was first 
developed in the 1960s (Kain et al, 1964). Initially patients had to inflate the device 
manually so night-time readings were not possible. However, subsequently 
automated brachial artery measurements over 24 hours became possible. 
 
 What does ABPM involve? 
A cuff connected to a portable electronic monitor is worn continuously by the patient 
for a period of 24 hours. The cuff is set to inflate at least twice an hour during waking 
hours (typically 8:00 to 22:00) and once an hour overnight (22:00 to 8:00). Average 
daytime blood pressure (calculated from at least 14 daytime readings) is used to 
diagnose hypertension (National Institute for Clinical Excellence, 2011).  
 
Careful fitting of these devices is essential for patient comfort and accurate readings, 
and all Health Care Professionals should undergo training and be assessed as 
competent in the skill. A full assessment should be undertaken before the ABPM is 
fitted. Blood pressure should be taken on both arms. The cuff is then placed next to 
the skin on the non-dominant arm unless there is a significant inter-arm difference in 
the blood pressure (suggested as >10mmHg by Clark et al, 2012), when it should be 
placed on the arm with the highest blood pressure.  
 
Patients taking anti-coagulant therapy or with fragile skin should be assessed for 
appropriateness, as continual monitoring may lead to localised bruising or 
compromise skin integrity. The presence of a hemiparesis or any other long standing 
injury to the arm selected for ABPM, as well as a history of mastectomy, nodal 
clearance or lymphoedema on the selected side, needs to be assessed and 
measurements taken on the unaffected side. It is also important to assess the 
patient’s general mental health status, or the presence of any learning difficulties or 
behavioural characteristics which may make ABPM an unsafe procedure. ABPM 
may be an uncomfortable experience, however it should not be painful. Patients 
should be instructed to remove the monitor if experiencing pain or obvious injury 
during the monitoring period. A local information sheet with contact telephone 
numbers should be devised. 
 
It is important to ensure the correct cuff size is used to maximise comfort and 
accuracy of the readings. Mid arm circumference should be measured and 
appropriate small, adult, large or extra-large cuff selected. The cable is then 
threaded across the patient’s shoulders and down to the monitor on their opposite 
hip: this can be attached to a belt or harness.   
 
Patients should be instructed to undertake their normal activities, with consideration 
to health and safety restrictions if worn at work. It is also advisable to limit 
cardiovascular exercise during the monitoring period to avoid multiple physiologically 
high blood pressure measurements in response to exercise. Patients should be 
advised that driving should be avoided or kept to a minimum throughout the 
monitoring period. If driving is unavoidable, patients should be shown how to switch 
the monitor off before starting their journey and switch it back on when they have 
arrived at their destination. Most devices will give a 5 second warning sound before 
inflation and patients should be instructed to either sit down or stand still when this 
occurs in anticipation of a reading being taken. Patients should remain still and not 
talk, with the arm supported during measurement. If worn overnight, the monitor 
should be placed under a pillow or to the patient’s side whilst the cuff remains in situ. 
 
After the 24 hour period has elapsed the patient returns the device to the surgery or 
clinic. Thereafter, stored readings are downloaded via a computer package. These 
are usually displayed in both graphical and tabulated format, with the mean 24 hour, 
daytime and night time readings given. Examples of the output from an ambulatory 
monitor are shown in Figure 1 (overleaf). 
 
It is important to consider practical issues relating to ABPM. Cuffs and pouches 
should be laundered between every use, according to local policy. Battery life also 
needs to be monitored and batteries changed following a set number of uses to 
avoid failure whilst on a patient.  
 
Interpretation of ABPM 
In order to compare to clinic BP readings, mean daytime systolic BP has to be 
adjusted upward by 5-10mmHg and mean daytime diastolic BP has to be adjusted 
upward by 5mmHg, but this assumed difference can vary considerably and is usually 
greater in people with a higher baseline BP and as people age [see below for 
influence on diagnostic thresholds]. Maintaining a diary of events during ABPM is 
useful, and it is best practice to ask patients to keep a sleep diary specifying the time 
that they went to bed and awoke, including daytime sleep if present. The average 
awake ambulatory BP can then be used, calculated according to the record kept by 
each patient. 
 
  
Figure 1: Examples of a 24 hour measurement of ambulatory blood pressure, 
recorded using an ABPM monitor.   
 
Readings from a normotensive individual with the average systolic and diastolic 
readings circled in black (A) and readings from a hypertensive individual with the 
average systolic and diastolic readings circled in red (B).  
 
In the diagnosis of hypertension, the most recent NICE guidelines (National Institute 
for Clinical Excellence, 2011) recommend use of the following thresholds and 
measurement techniques: 
 Stage 1 hypertension: initial clinic blood pressure 140/90 mmHg or higher and 
subsequent ABPM daytime average or home BP average blood pressure 
135/85 mmHg or higher.   
 Stage 2 hypertension: initial clinic blood pressure 160/100 mmHg or higher 
and subsequent ABPM daytime average or home BP average blood pressure 
150/95 mmHg or higher.  
 
What can ABPM be used for? 
Ambulatory blood pressure monitoring is typically used where there is uncertainty in 
diagnosis, resistance to treatment, to determine diurnal variation, or concerns about 
variability and “white coat” effect (Redon et al, 1998; Verdecchia, 2001; Whitworth 
and World Health Organisation, International Society of Hypertension Writing Group, 
2003). It has therefore arguably become the de facto reference standard for the 
diagnosis of hypertension (Hodgkinson et al, 2011a).  
 
ABPM, like other out-of-office measurements, is believed to reduce the white coat 
effect, in which a patient's blood pressure is elevated during the examination process 
due to the stress of being in a medical situation (Verdecchia et al, 2004). 
 
A major advantage of ABPM is that it provides more information than either home or 
clinic BP measurements because more readings are taken. Clinical BP 
measurements in particular are fewer in number, and so more subject to general 
variability including regression to the mean. 24-hour ABPM allows estimates of 
increased cardiac risk including excessive BP variability or failure to reduce BP 
nocturnally. Blood pressure variability is recognised as a key element in subsequent 
risk of cardiovascular disease and stroke in particular (Rothwell, 2010). However, 
whilst some antihypertensives affect variability more than others (Webb et al, 2010), 
it is not yet clear how measurement of variability can be incorporated in clinical 
management. 
 
In addition, only ABPM can determine night-time dipping patterns, which have 
important prognostic implications. ABPM allows BP to be intermittently monitored 
during sleep, and is useful to determine whether the patient is a dipper or non-
dipper, i.e. whether or not BP falls at night compared to daytime values. Absence of 
a night-time dip is associated with poorer health outcomes, including increased 
mortality (Minutolo et al, 2011).  
 
The exaggerated morning surge in blood pressure (MBPS) is thought to be a risk 
factor for wake up stroke (which is implicated in up to 27% of all ischemic strokes 
[Fink et al, 2002]) and indeed other cardiovascular events that occur in the morning 
hours (Kario and White, 2008; Kario, 2010; White, 2010). MBPS is commonly 
assessed by ABPM and defined as the sleep-trough surge, calculated by subtracting 
the morning BP (mean of four readings over two hours just after wake-up) from the 
lowest nocturnal BP (mean of three readings centred around the lowest night time 
BP) (Kario et al, 2003; Kario, 2010). However, there are several alternative 
definitions but only ABPM can measure the sleep-trough surge, prewaking surge, or 
rising blood pressure surge that has been shown to coincide with acute 
cardiovascular events, such as myocardial infarction, stroke, sudden cardiac death 
and ischemic episodes.  
 
Why is ABPM particularly important now? 
Initial management of hypertension has conventionally required a diagnosis based 
on several elevated clinic or office blood pressure measurements (Williams et al, 
2004; JNC 7, 2004; National Institute for Clinical Excellence, 2006; National 
Collaborating Centre for Chronic Conditions, 2006). Even in the infancy of ABPM, 
early evidence found ambulatory BP correlated with target organ damage. Now it is 
acknowledged that ABPM not only estimates “true” mean blood pressure more 
accurately than clinic measurement, because multiple readings are taken, but that it 
has better correlation with a range of cardiovascular outcomes and end organ 
damage (Imai et al, 1996; Fagard et al, 1997; Mancia et al, 1997; Staessen et al, 
1999; Ohkubo et al, 2000; Verdecchia, 2000). 
 
The benefits of out-of-office techniques, in particular ABPM, include the correct 
diagnosis of white coat hypertension, and improved diagnostic accuracy. Indeed, the 
weight of evidence suggests ABPM is the best prognostic indicator, followed by 
home BP monitoring, and then clinic BP monitoring. Thus ABPM is best able to 
predict those patients who require treatment. Its greater use should result in both 
improved outcomes for patients and lower costs to the NHS through both reduced 
anti-hypertensive prescribing and better targeting resulting in fewer cardiovascular 
events. Furthermore, out-of-office methods can enable a diagnosis to be made more 
quickly. 
 
A possible objection is that ambulatory monitors are more expensive than those 
used in the home or clinic setting with a median NHS cost of around £1000 
(Lovibond et al, 2011). However, a recent systematic review (Hodgkinson et al, 
2011a) and cost-effectiveness study (Lovibond et al, 2011) found ABPM is more 
accurate than both clinic and home monitoring in diagnosing hypertension and that a 
diagnostic strategy for hypertension using ambulatory monitoring following an initial 
raised clinic reading would reduce misdiagnosis and be cost saving for the NHS, 
prompting a change in the latest NICE guidelines (National Institute for Clinical 
Excellence, 2011). This is because additional costs from ambulatory monitoring are 
counter-balanced by cost savings from better targeting of treatment which accrue 
over time.  
 
Furthermore, many people currently labelled as hypertensive from clinic BP 
monitoring alone may not have hypertension. This has significant implications when 
the adverse effects of labelling per se on otherwise healthy individuals are 
considered (Haynes et al, 1978; Bloom and Monterossa, 1981; Macdonald et al, 
1984; Johnstone et al, 1984). 
 
A caveat 
Accuracy in measuring BP is fundamental to the correct diagnosis of hypertension 
and ABPM has been shown to be the most accurate non-invasive method of 
assessing BP. Nevertheless, it remains absolutely essential that the correct 
procedures in taking BP, as outlined above, are followed. Training is also required to 
minimise the possibility of poor readings caused by poor technique. Use of an 
accurate blood pressure monitoring device is also critical to the correct diagnosis of 
hypertension. 
 
As with clinic blood pressure measurement, an independently validated device 
should always be used. Validation is the process by which accuracy can be ensured 
and this involves a comparison of the readings from the device with those from a 
mercury sphygmomanometer. Critically, any ambulatory machine used should be 
validated by an appropriate protocol to ensure its accuracy. Monitors can be 
validated according to one or more of the AAMI/ ISO (Association for the 
Advancement of Medical Instrumentation, 1993; International Organization for 
Standardization, 2009), BHS (O’Brien et al, 1993a) or ESH-IP (O’Brien et al, 2002; 
O’Brien et al, 2010) protocols. Lists of current validated monitors are available at the 
BHS (British Hypertension Society, 2013) and DABL (O’Brien et al, 2013) websites.  
 
A recent systematic review found published validation studies assessed most 
ambulatory monitors as accurate but that many such studies failed to adhere to the 
underlying protocols (Hodgkinson et al, 2013). Furthermore, most monitors which 
“passed” validation showed significant variation in blood pressure from the reference 
standard, highlighting inadequacies in older validation protocols. 
 
Finally, the drift in accuracy of a new device over time is unknown. Monitors should 
therefore be recalibrated at regular intervals. There are a number of companies who 
offer this service, though it is important to ensure that they meet ISO9001 standards.   
 
Disadvantages of ABPM 
ABPM is not widely available, with only around one in every twenty diagnoses made 
with an ABPM machine, and to date these have been largely confined to larger GP 
practices and specialist units (Hodgkinson et al, 2011b). This is likely to change 
following the recent update to NICE guidelines (National Institute for Clinical 
Excellence, 2011), but as the guidelines are not mandatory, questions remain over 
whether GPs will be convinced enough of the benefits to pay for the devices despite 
their longer-term cost-effectiveness (Lovibond et al, 2011). 
 
Modern ambulatory monitors are generally lightweight, comfortable and easy to 
wear, quiet, and automated; however, some patients complain that they are 
disturbed during sleep, which may impact compliance and could also influence 
detection of the dipper status (Leary and Murphy, 1998). This may be a particular 
problem for individuals with very high blood pressure, as they are likely to experience 
frequent repeat readings and a higher cuff pressure. Home monitoring can be used 
to confirm the diagnosis if the patient cannot tolerate ABPM well. 
 
Does ABPM work in special populations?  
Accurate diagnosis is important for correct diagnosis and management but there is 
evidence that ambulatory blood pressure monitors may be less reliable in some 
patient groups including elderly patients, haemodialysis patients, pregnant women, 
and children (Hodgkinson et al, 2013), whilst oscillometric measurement is difficult in 
the presence of arrhythmias such as atrial fibrillation. This reflects the difficulty in 
measuring blood pressure in these populations as much as the performance of the 
ambulatory monitors, but it is important that clinicians are aware of this difficulty. 
 
Gestational hypertension is a leading cause of direct maternal death in the UK 
(National Institute for Clinical Excellence et al, 2004).  However, in four studies which 
assessed an ABPM monitor validated in the general population (SpaceLabs 90207) 
in pregnancy using the BHS criteria (O’Brien et al, 1993b; Shennan et al, 1993; 
Franx et al, 1997; Elvan-Taspinar et al, 2003), two studies found the monitors tested 
failed to meet the required standard of accuracy (O’Brien et al, 1993b; Franx et al, 
1997). The few studies which have examined ABPM in sufficient pre-eclamptic 
subjects, again assessing the same monitor, found the device failed the BHS criteria 
and performed poorly (Natarajan et al, 1999; Elvan-Taspinar et al, 2003). Similarly, 
in children the same monitor failed with only 50% of readings within 5mmHg (Belsha 
et al, 1996). This highlights a need for further research into blood pressure 
measurement in these special populations. 
 
Conclusions 
Ambulatory monitoring provides an accurate assessment of blood pressure over a 
24 hour period, is better correlated with prognosis than clinic measurement and can 
guide both diagnosis and further management.  
 
Several aspects of ambulatory monitoring remain unclear including:  
 How to deal with discordant results between home and ambulatory 
monitoring?  
 How often to undertake ABPM?  
 Whether additional data from new technology adds value to ABPM, for 
example, pulse wave analysis or continuous non invasive ambulatory 
measurement or cuffless devices?  
 As ABPM becomes more common place in primary as well as secondary care, these 
questions should become clearer.  
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Figure 1: Examples of a 24 hour measurement of ambulatory blood pressure, 
recorded using an ABPM monitor.   
 
Readings from a normotensive individual with the average systolic and diastolic 
readings circled in black (A) and readings from a hypertensive individual with the 
average systolic and diastolic readings circled in red (B).  
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